Anticoagulation and TAVI: comparison of two strategies
A randomized noninferiority study comparing two perioperative anticoagulation strategies for TAVI.
Valvulopathies
COMMENCE at 7 years: Resilia tissue continues to perform well, though it is not infallible
This report details the 7-year outcomes of the COMMENCE study, which evaluates the results of aortic valve replacement using the Edwards Inspiris RESILIA® prosthesis.
Impact of the TRI-SCORE on valve surgery for tricuspid regurgitation
This article examines the impact of the TRI-SCORE on surgical outcomes compared to conservative management for severe functional tricuspid regurgitation. It evaluates survival according to risk categories based on this scoring system using data from the TRIGISTRY registry.
Should current age recommendations for the use of bioprostheses in the mitral position be reconsidered?
A multicenter retrospective study addressing the durability of mitral bioprostheses across different age groups, aiming to determine their longevity and the risk of reintervention in younger patients.
State-of-the-art in sutureless aortic valve replacement: where do we stand?
Critical evaluation of the methodology and results of the review published in JACC on the main studies investigating the efficacy and safety of sutureless aortic prostheses compared to conventional aortic valve replacement.
New tools for the surgical treatment of complex tricuspid regurgitation
Review emphasizing the experience of San Raffaele Hospital in the surgical management of tricuspid regurgitation when annuloplasty alone is insufficient, using clover and edge-to-edge repair techniques.
Treatment of transcatheter aortic valve (TAVI) thrombosis: a critical analysis
A review of the incidence, classification, and potential recommendations for clinical management of thrombosis associated with TAVI.
Percutaneous repair to treat functional mitral regurgitation: edge-to-edge therapies are here to stay
A meta-analysis summarizing current evidence from the three main studies on the use of edge-to-edge therapies to treat moderate-to-severe functional mitral regurgitation in patients with symptomatic heart failure.
What can structural interventions offer in heart failure? beyond valvular diseases
A bibliographic review of the current percutaneous devices available for the treatment of heart failure, including interventions on cardiac valves, left ventricular remodeling, or other approaches.
Aortic stenosis in asymptomatic patients: Early intervention doesn’t make the sun rise any sooner
Review of the current evidence on the invasive treatment of severe aortic stenosis in asymptomatic patients, with special emphasis on the results from the EVOLVED and EARLY-TAVR trials.